Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Approval for Desonide Ointment, 0.05%. The company has also submitted press release on the same.
The above information is a part of company’s filings submitted to BSE.